Company Filing History:
Years Active: 2022-2025
Title: Innovations of Yu-Chih Pan in Biotechnology
Introduction
Yu-Chih Pan is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds for therapeutic applications. With a total of 2 patents, his work focuses on addressing critical medical conditions through innovative chemical solutions.
Latest Patents
Yu-Chih Pan's latest patents include groundbreaking research on heterocyclic pyrazole derivatives. These compounds serve as type III receptor tyrosine kinase inhibitors, which can act against protein kinases, especially Class III RTKs such as FLT3, PDGFRα, c-KIT, and CSF-1R. The compounds are designed for the treatment of diseases mediated by these kinases, including various cancers, autoimmune diseases, and bone resorptive diseases. Another significant patent involves heterocycle compounds targeting the Tyro3, Axl, and MerTK family of receptor tyrosine kinases. This patent discloses methods for treating disorders mediated by these kinases, showcasing the potential of these compounds in pharmaceutical applications.
Career Highlights
Yu-Chih Pan is currently associated with the Development Center for Biotechnology. His work at this institution has been pivotal in advancing research and development in the field of biotechnology. His innovative approaches and dedication to scientific research have positioned him as a key figure in the industry.
Collaborations
Yu-Chih Pan has collaborated with notable colleagues, including Shih-Chieh Yen and Chu-Bin Liao. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their projects.
Conclusion
Yu-Chih Pan's contributions to biotechnology through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapeutic solutions.